Coronary Microvascular Dysfunction in Angina Patients With Non-obstructive Coronary Artery Disease (ANOCA-CMD)

Last updated: July 10, 2024
Sponsor: China-Japan Friendship Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Coronary Artery Disease

Atherosclerosis

Heart Disease

Treatment

N/A

Clinical Study ID

NCT06503640
2023-KY-077
  • Ages > 18
  • All Genders

Study Summary

The goal of this observational study is to explore the incidence and effect on prognosis of coronary microvascular dysfunction in patients present of stable anginal symptoms, a clinical indication for invasive coronary angiography, and no hemodynamically significant epicardial coronary artery disease, defined as fractional flow reserve (FFR) >0.80.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • presence of stable anginal symptoms, a clinical indication for invasive coronaryangiography, and no hemodynamically significant epicardial coronary artery disease,defined as fractional flow reserve (FFR) >0.80

Exclusion

Exclusion Criteria:

  1. acute myocardial infarction

  2. significant valvular heart disease

  3. advanced chronic kidney disease

  4. patients with significant epicardial coronary artery stenosis (>70% in major vesselsby diagnostic coronary angiography) needing percutaneous coronary intervention

  5. patients unable to provide written informed consent

Study Design

Total Participants: 100
Study Start date:
July 01, 2023
Estimated Completion Date:
December 31, 2025

Connect with a study center

  • China-Japan Friendship Hospital

    Beijing, Beijing 100029
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.